Faced with the current shortage of medicines, Bern wants to extend mandatory reserves of drugs and the obligation to declare stocks, says a top government official.
This content was published on
2 minutes
Keystone-SDA/jc
Italiano
it
Di fronte alla carenza di farmaci, la Svizzera prevede di incrementare le scorte di medicinali
Anti-epileptic drugs and medicines for Parkinson’s disease should be included in the mandatory reserves, Christoph Amstutz of the Federal Office for National Economic SupplyExternal link (FONES) told SRF radio on Friday. Medicines for mental disorders should also be included, said Amstutz, who heads the Therapeutic Products Division at FONES. If these drugs were to run out, it could have a very harmful effect on patients, he added.
For the first time, the authorities have classified the supply of certain drugs as “problematic”, Amstutz told SRF. In the past it has always been possible to resort to compulsory stockpiling or exchange of certain drugs in case of supply problems. Now, however, not all oral antibiotics are available, but that does not mean that people will die because of it.
Current shortages mostly concern medicines for children, according to Amstutz. This is mainly a seasonal phenomenon, due to the flu epidemic and infections in toddlers, but is also a side effect of the pandemic. He said more antibiotics have been used than in previous years.
The next stage would be if the situation were deemed “critical”, with individual products or whole groups of therapeutic agents no longer available. “I hope this will not happen in the future,” Amstutz said.
FONES is also working with the Federal Office of Public Health (FOPH) to develop a plan for security of medicine procurement. The intention is to make virtually all drugs reimbursed by health insurance funds subject to compulsory registration.
Is your place of origin, your Heimatort, important to you?
Every Swiss citizen has a Heimatort, a place of origin, but many have never visited theirs. What’s your relationship with your Heimatort? What does it mean to you?
Novartis and Sanofi call for higher drug prices in Europe
This content was published on
Swiss and French pharmaceutical companies Novartis and Sanofi argue that the EU should adjust its drug prices to better align with those in the US.
WHO braces for staff cuts in Geneva amid US funding withdrawal
This content was published on
WHO’s Director-General warned US budget cuts are putting the agency in financial trouble, leading to management cuts in Geneva.
Parmelin meets Swiss businesses in US as IMF predicts 0.9% growth for Switzerland
This content was published on
Economics Minister Guy Parmelin met Swiss businesses in the US during IMF and World Bank meetings. The IMF now forecasts 0.9% GDP growth for Switzerland.
An atomic ‘tick-tock’ with Swiss technology heads to space to test the Einstein effect
This content was published on
On Monday, the European Space Agency (ESA) launched the ACES set of atomic clocks to measure the effect of gravity on the passage of time.
Swiss Guard swearing-in ceremony postponed following Pope Francis death
This content was published on
The swearing-in ceremony of the Pontifical Swiss Guard, which usually takes place on May 6 each year, has been postponed to a date to be announced next autumn.
Addiction experts warn of shortage of methadone tablets
This content was published on
The Swiss Society of Addiction Medicine (SSAM) has warned of a possible shortage of methadone tablets in the coming weeks.
This content was published on
Switzerland is experiencing medicine shortages due to supply chain issues linked to Covid lockdowns in China and the Ukraine war.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.